nitroflurbiprofen has been researched along with Focal Segmental Glomerulosclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Nucci, G; Donato, JL; Fujihara, CK; Malheiros, DM; Poli, A; Zatz, R | 1 |
1 other study(ies) available for nitroflurbiprofen and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Nitroflurbiprofen, a new nonsteroidal anti-inflammatory, ameliorates structural injury in the remnant kidney.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Flurbiprofen; Glomerulosclerosis, Focal Segmental; Hemodynamics; Kidney; Male; Nephrectomy; Nitric Oxide; Rats; Rats, Wistar | 1998 |